Literature DB >> 10657716

Clinicopathologic study on prognostic markers in IgA nephropathy.

J Mera1, S Uchida, M Nagase.   

Abstract

BACKGROUND/AIM: Few prognostic markers have found general acceptance in IgA nephropathy (IgAN). The aim of the present study was to search for significant predictor(s) at the time of biopsy.
METHODS: Fifty-five patients with IgAN undergoing evaluation and treatment at our institution were examined regarding clinicopathologic features at the time of renal biopsy and, if possible, at follow-up. Factors predictive of outcome were evaluated. Renal histopathology was quantified using a glomerulosclerosis index (GSI), a tubulointerstitial index (TII), and a crescent index (CI).
RESULTS: The serum creatinine concentration (S-Cr) showed positive correlations with proteinuria and serum total cholesterol concentration, as well as with histopathologic findings. Heavy proteinuria (> or =3.0g/24 h) was associated with higher S-Cr and greater severity of pathologic abnormalities than with milder proteinuria. At follow-up, 6 patients progressed to chronic renal insufficiency, in whom the S-Cr increased by at least 50% to reach or exceed 1.5 mg/dl (132.6 micromol/l). By univariate analysis, elevated GSI, TII, and S-Cr, presence of nephrotic syndrome, elevated CI, and elevated total cholesterol were found to be negative predictors, in descending order of odds ratio. In multivariate analysis, however, only TII independently predicted unfavorable outcome.
CONCLUSION: Renal biopsy in IgAN may be the most powerful predictor for renal outcome; an advanced tubulointerstitial lesion is unfavorable. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657716     DOI: 10.1159/000045563

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  5 in total

Review 1.  Pathology of IgA nephropathy.

Authors:  Ian S D Roberts
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

2.  Prediction of diagnosis of immunoglobulin A nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading.

Authors:  Kazutaka Nakayama; Isao Ohsawa; Atsuko Maeda-Ohtani; Maki Murakoshi; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

3.  Comparison of the effects of valsartan plus activated vitamin D versus valsartan alone in IgA nephropathy with moderate proteinuria.

Authors:  Liu Xiaowei; Wang Bo; Li Li; Zhang Peng
Journal:  Int Urol Nephrol       Date:  2019-11-25       Impact factor: 2.266

4.  Ameliorating Effect of Gemigliptin on Renal Injury in Murine Adriamycin-Induced Nephropathy.

Authors:  Da Rae Kim; Shin Yeong Lee; Jin Sug Kim; Yang Gyun Kim; Ju-Young Moon; Sang Ho Lee; Tae Won Lee; Chun Gyoo Ihm; Kyung Hwan Jeong
Journal:  Biomed Res Int       Date:  2017-02-23       Impact factor: 3.411

5.  Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy.

Authors:  M P Graham-Brown; A Singh; J Wormleighton; N J Brunskill; G P McCann; J Barratt; J O Burton; G Xu
Journal:  BMC Nephrol       Date:  2019-07-11       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.